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Received 5 March 2007; received in revised form 2 April 2007; accepted 4 April 2007AbstractThe field efficacy of eprinomectin against a natural infection with Muellerius capillaris was evaluated in adult dairy goats. A
total of 13 animals were included in a crossover treatment study. Animals were treated with eprinomectin (0.5 mg/kg) in the spring
and again in the autumn of 2006, and monitored by enumeration of the lungworm larvae per gram of faeces (LPG). The reduction in
LPG on days 7, 21 and 42 after treatment was used to evaluate the anthelmintic efficacy. Both in the spring and in the autumn a 100%
reduction (P < 0.01) in LPG was observed on days 21 and 42. These results illustrate that eprinomectin applied as a topical pour-on
is a practical alternative to benzimidazole treatment of lungworms in dairy goats. No adverse reactions to the eprinomectin
treatment were observed.
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The small lungworm Muellerius capillaris is a
common parasite of grazing goats worldwide. Although
the clinical outcome of a M. capillaris infection seems
more pronounced in goats compared to sheep (Beres-
ford-Jones, 1967), most often goats do not display clear
clinical symptoms except in heavy infections. The
clinical symptoms include failure to thrive, coughing,
dyspnea and sometimes mortality. In adult dairy goats
infection can also result in depressed milk production
(Bliss and Greiner, 1985). For the treatment of
lungworm infections in goats, several benzimidazole
compounds, such as fenbendazole, albendazole, cam-
bendazole and oxfendazole (Cremers, 1983; Bliss and
Greiner, 1985; Helle, 1986), and the probenzimidazole* Corresponding author. Tel.: +32 9 264 73 93; fax: +32 9 264 74 96.
E-mail address: thomas.geurden@ugent.be (T. Geurden).
0304-4017/$ – see front matter # 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.vetpar.2007.04.003netobimine (Cabaret, 1991) were shown to reduce the
larval excretion, although not completely.
Eprinomectin is an unapproved topically applied
potent macrocyclic lactone (ML), subject to minimal
partioning into milk of lactating goats (Dupuy et al.,
2001). Although it is therefore a promising alternative
for benzimidazole treatment, the efficacy of eprino-
mectin against lungworms in dairy goats has not yet
been evaluated. Furthermore, the need for a higher dose
rate for anthelmintic treatment was previously sug-
gested based on the low plasma concentration of
eprinomectin in goats after topical application (Alvin-
erie et al., 1999). For the treatment of gastrointestinal
nematodes, such as Teladorsagia circumcinta and
Trichostrongylus colubriformis, eprinomectin was
indeed shown to be effective in reducing faecal egg
counts (Cringoli et al., 2004) and worm burdens
(Chartier and Pors, 2004) in goats, when twice the cattle
dose rate (1 mg/kg bodyweight) was applied. It is
however not certain if a similar double dose rate is
required for treatment of a natural M. capillaris
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Table 1
The individual LPG and the geometric mean (gmean) LPG in the
control (C) and treatment (T) group on the different sampling days
(D), and the percentage reduction (red) for the spring treatment
Animal no. Group LPG D0 LPG D7 LPG D21 LPG D42
1 C 1 5 2 1
2 C 15 3 4 2
3 C 10 4 1 4
4 C 19 3 4 3
gmean 8 2 2 2
5 T 1 6 0 0
6 T 7 7 0 0
7 T 14 30 0 0
8 T 16 8 0 0
9 T 17 5 0 0
10 T 45 24 0 0
gmean 11 2 0 0
red 14% 100%* 100%*
* Significant (P < 0.01).infection. Therefore, in the present study the field
efficacy of a topical pour-on application at a dose rate of
0.5 mg/kg against a natural M. capillaris infection was
evaluated.
2. Materials and methods
Acrossover studydesignwas used to evaluate the field
efficacy of eprinomectin in adult dairy goats (Toggen-
burger), following the guidelines described by Ver-
cruysse et al. (2001). Animals were allowed to graze
throughout the year, and had access to shelter at all time.
In the spring of 2006, 10 animals were selected based on
faecal excretion of larvae: 4 animals were randomly
assigned to the control group and 6 animals to the
treatment group. None of these goats had been treated
with an anthelmintic for at least 1 year prior to the study.
The lenght of the washout period was based on the
knowledge that the systemic availability of eprinomectin
in goats is less than in cattle (Alvinerie et al., 1999) and
that the remanent efficacy is maximum 28 days in cattle
(Cramer et al., 2000).After awashout periodof 6months,
13 animals were selected for the second treatment in the
autumn of 2006. These included 9 of the 10 animals used
in the spring.One animal (AnimalNo. 2)was not selected
in the autumn, due to absence of larvae prior to treatment.
Four first grazing season goats were added to the study.
The six animalswhich had been treated in the springwere
assigned to the control group. The three animals of the
spring control group and the four additional animalswere
assigned to the treatment group. All animals in the
treatment groups were weighed using a calibrated scale
and received a pour-on application of eprinomectin at a
dose rate of 0.5 mg/kg.
Prior to treatment (D0), and 7 (D7), 21 (D21) and 42
(D42)daysafter treatment individual faecal sampleswere
taken from all animals included in the study. The number
of larvae per gram of faeces (LPG) was determined using
the Baermann technique which has been shown to be a
reliable diagnostic assay for the detection of lungworm
larvae in goats (Papadopoulos et al., 2004). Identification
of larvae was performed based on morphological
characteristics (Hiepe et al., 1985). The geometric mean
LPG was calculated at each sampling day. The treatment
efficacy was measured based on the reduction in LPG for
the animals in the treatment group compared to the
control group. The reduction in larval excretion was
calculated using the Henderson–Tilton formula (Hen-
derson and Tilton, 1955):
100 b 1 Ta Cb
Tb Ca cTb and Ta being the geometric mean LPG in the
treatment group before and after treatment, and Cb
and Ca being the geometric mean LPG in the control
animals before and after treatment. Differences in
larval excretion were analysed using a Mann–Whit-
ney test for pairwise comparison of the treatment
group with the control group. Probability (P) values
<0.05 were considered to indicate significant differ-
ences.
3. Results
At all sampling days the larvae retrieved from the
Baermann were identified as M. capillaris. The
individual LPG, the geometric mean LPG and the
percentage reduction of the spring treatment are
presented in Table 1. Both in the treatment group and
the control group all animals were positive prior to
treatment. The LPG was significantly (P < 0.01)
lower in the treatment group compared to control
group at D21 and D42. The results for the treatment in
autumn are presented in Table 2. Both in the treatment
group and the control group all animals were positive
prior to treatment. The LPG was significantly
(P < 0.01) lower in the treatment group compared
to control group at D7, D21 and D42. None of the
control animals displayed clinical symptoms of
lungworm infection during the follow-up period. Both
in the spring and in the autumn none of the treated
animals displayed adverse reactions during or after
treatment.
T. Geurden, J. Vercruysse / Veterinary Parasitology 147 (2007) 190–193192
Table 2
The individual LPG and the geometric mean (gmean) LPG in the
control (C) and treatment (T) group on the different sampling days
(D), and the percentage reduction (red) for the autumn treatment
Animal no. Group LPG D0 LPG D7 LPG D21 LPG D42
5 C 2 2 3 15
6 C 4 3 4 18
7 C 6 7 10 4
8 C 8 9 1 2
9 C 91 56 7 3
10 C 4 6 3 7
gmean 8 7 4 6
1 T 10 1 0 0
3 T 160 0 0 0
4 T 13 3 0 0
11 T 7 0 0 0
12 T 5 1 0 0
13 T 2 0 0 0
14 T 1 0 0 0
gmean 9 0 0 0
red 95%* 100%* 100%*
* Significant (P < 0.01).4. Discussion
This is the first study to evaluate the field efficacy of
eprinomectin against a naturalM. capillaris infection in
adult dairy goats. The results of the present study
indicate the high efficacy of eprinomectin at a dose rate
of 0.5 mg/kg bodyweight against a naturalM. capillaris
infection. For the treatment of gastrointestinal nema-
todes in goats, a double dose (1 mg/kg bodyweight) has
been recommended (Chartier and Pors, 2004; Cringoli
et al., 2004; de Souza Chagas et al., 2007), based on the
low concentration of eprinomectin in plasma after
topical application (Alvinerie et al., 1999). The results
of the present study however suggest that M. capillaris
is not a dose limiting species and indicate that treatment
with eprinomectin at a lower dose rate of 0.5 mg/kg
bodyweight significantly reduced the larval excretion in
goats. Reduction of larval excretion does not implicate
that animals are no longer infected, due to the specific
location of the adult worms in the lung parenchym
(Papadopoulos et al., 2004; Rehbein and Visser, 2002),
but does lower the infection of the intermediate host
snail population and will subsequently reduce the
exposure of animals to infection on pasture, preventing
continuous re-infection and the development of clinical
symptoms and production losses.
In sheep, both ivermectin (oral administration) and
moxidectin (oral and subcutaneous administration)
have been shown to effectively reduce the lungwormburden and faecal excretion of lungworm larvae
(Papadopoulos et al., 2004; Rehbein and Visser,
2002). However, both have a milk-withdrawal period
in sheep and cattle. Since the maximum level of residue
in goat milk was shown to remain below the maximum
acceptable level permitted in lactating cattle (Dupuy
et al., 2001; Anastasio et al., 2005), the major advantage
of eprinomectin over moxidectin and ivermectin, is the
subsequent zero milk-withdrawal period (Dupuy et al.,
2001; Anastasio et al., 2005). Eprinomectin is however
not registered for use in goats.
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